In Brief: Circon
This article was originally published in The Gray Sheet
Executive Summary
Circon: Poised to begin sales of the VaporTrode electrode and Rotating Continuous Flow Resectoscope system "in early 1995," Circon announces Jan. 9. The single-use VaporTrode, priced at $150, is designed for urological procedures and is billed as a less expensive alternative to transurethral resection of the prostate and laser vaporization, both of which are used to treat benign prostatic hyperplasia. The Rotating Continuous Flow Resectoscope, which costs about $8,000, is "ideally suited for the VaporTrode electrode," Circon says, and "reduces trauma caused by" conventional instruments...